B74-15 The Social Effects of Covid-19 Pandemic on Pulmonary Rehabilitation in Patients With Heart and Lung Disease

Abstract Rationale Pulmonary rehabilitation (PR) is vital for managing chronic heart and lung diseases, improving functional capacity and quality of life. Compliance with PR is crucial but often influenced by social and environmental factors. The COVID-19 pandemic introduced significant challenges, including social isolation and healthcare disruptions, impacting PR participation and adherence. This study examines the pandemic’s effects on PR programs and patient outcomes. Method: This IRB-approved retrospective analysis (2019-2023) evaluated a single-center PR program. Key parameters included patient enrollment, program duration, clinical outcomes (6MWD, FEV1, CAT score), and tobacco use trends to assess the pandemic’s impact on PR. Results Patient Enrollment: Declined sharply in 2020 (N = 46) vs. 2019 (N = 108), remaining low in 2023 (N = 36). Program Duration: Increased from 93 days (2019) to 177 days (2023), reflecting pandemic adaptations. Clinical Outcomes: 6MWD improvements varied, lowest in 2022 (123.2 ft, 14%) and highest in 2023 (277.1 ft, 34%). FEV1 improvements were modest (0.06% in 2020 to 0.79% in 2023). CAT scores showed minimal changes. Tobacco Use: Current smokers decreased from 6.5% (2019) to 2.8% (2023), while former smokers peaked at 88.9% (2021). Conclusion The COVID-19 pandemic significantly impacted PR programs, reducing enrollment and extending durations. Despite challenges, adaptive strategies may have mitigated some effects, as seen in improved 6MWD in 2023. Reduced tobacco use suggests pandemic-related behavioral changes. These findings highlight the need for innovative, patient-centered PR approaches to address social determinants and ensure accessibility during public health crises. Future research should focus on long-term outcomes and strategies to enhance compliance in post-pandemic rehabilitation. This abstract is funded by: None